Cargando…

High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML

SIMPLE SUMMARY: The interactions between Acute Myeloid Leukaemia (AML) cells and the surrounding bone marrow (BM) tissue contribute to blocking the efficacy of current drug treatments and to the relapse of patients. Relapsing AML tumours are refractory to current therapies and remain untreatable. De...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arroyo-Berdugo, Yoana, Sendino, Maria, Greaves, David, Nojszewska, Natalia, Idilli, Orest, So, Chi Wai, Di Silvio, Lucy, Quartey-Papafio, Ruby, Farzaneh, Farzin, Rodriguez, Jose Antonio, Calle, Yolanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093176/ https://www.ncbi.nlm.nih.gov/pubmed/37046649 http://dx.doi.org/10.3390/cancers15071988

Ejemplares similares

Triggering a Second T Cell Receptor on Diabetogenic T Cells Can Prevent Induction of Diabetes
por: Fossati, Gianluca, et al.
Publicado: (1999)

Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics
por: Kikuchi, Hugh, et al.
Publicado: (2023)

TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells
por: Benzing, Christian, et al.
Publicado: (2019)

The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice
por: Tye, Gee Jun, et al.
Publicado: (2015)

Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS
por: Page, Mark, et al.
Publicado: (2014)

IL-2-based approaches to Treg enhancement
por: Harris, Ffion, et al.
Publicado: (2022)

P03-03. Protection against SIV by anti HLA class II specific antibody in the macaque model
por: Robinson, MJ, et al.
Publicado: (2009)

Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
por: Graham, Charlotte Elizabeth, et al.
Publicado: (2021)

Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours
por: Greaves, David, et al.
Publicado: (2022)

Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells
por: Li, Bo, et al.
Publicado: (2011)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
por: Lam, Stephen S.Y., et al.
Publicado: (2020)

AML-337: Targeting E-Selectin with GMI-1271 Overcomes Microenvironment-Mediated Resistance to Venetoclax/HMA Therapy
por: Chang, Kyung Hee, et al.
Publicado: (2020)

Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination
por: Lehner, Kara M., et al.
Publicado: (2023)

Periodontal status and oral hygiene practices among adults in a peri-urban fishing community in Ghana
por: Tormeti, Daniel, et al.
Publicado: (2022)

A-1210477, a selective MCL-1 inhibitor, overcomes ABT-737 resistance in AML
por: Wang, Qing, et al.
Publicado: (2019)

Metabolic Rewiring Is Essential for AML Cell Survival to Overcome Autophagy Inhibition by Loss of ATG3
por: Baker, Fatima, et al.
Publicado: (2021)

Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection
por: Liccardo, Francesca, et al.
Publicado: (2023)

Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2021)

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance
por: Levin, May, et al.
Publicado: (2021)

P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV
por: Manoussaka, MS, et al.
Publicado: (2009)

Replication kinetics and persistence of a conditionally live attenuated SIV (SIVrtTA) in vivo confers protection against SIVmac239 wild-type challenge in a rhesus macaque model
por: Berry, Neil, et al.
Publicado: (2009)

De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2017)

A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
por: Drenberg, Christina D., et al.
Publicado: (2019)

Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment
por: Nehrbas, Jill, et al.
Publicado: (2020)

Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014
por: Łyszczarz, Błażej, et al.
Publicado: (2017)

Macroeconomic and Social Indicators to Launch the PM-Based VBHC Model in the Healthcare System in Poland
por: Nojszewska, Ewelina, et al.
Publicado: (2022)

Production function for modeling hospital activities. The case of Polish county hospitals
por: Sielska, Agata, et al.
Publicado: (2022)

Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage
por: Niu, Li-Ting, et al.
Publicado: (2021)

Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
por: Emdal, Kristina B., et al.
Publicado: (2022)

The Interleukin-17 Induced Activation and Increased Survival of Equine Neutrophils Is Insensitive to Glucocorticoids
por: Murcia, Ruby Yoana, et al.
Publicado: (2016)

Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models
por: Chalabi Hajkarim, Morteza, et al.
Publicado: (2022)

Tackling TKI resistance in AML: A commentary on “Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.” by Yamatani et al.
por: Hatırnaz Ng, Özden, et al.
Publicado: (2022)

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model
por: Page, Mark, et al.
Publicado: (2012)

AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
por: Gardini, Alessandro, et al.
Publicado: (2008)

MAP4K1 expression is a novel resistance mechanism and independent prognostic marker in AML-but can be overcome via targeted inhibition
por: Knight, Tristan E., et al.
Publicado: (2021)

Favorable outcomes of NPM1(mut) AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance
por: Khan, I., et al.
Publicado: (2023)

PB1774: PHARMACOLOGICAL STRATEGIES TO OVERCOME RESISTANCE IN AML CELL LINE MODELS HARBORING ACTIVATING FLT3-ITD AND PTPN11 MUTATIONS
por: Fleischmann, Maximilian, et al.
Publicado: (2023)

The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

Emerging roles for microtubules in angiosperm pollen tube growth highlight new research cues
por: Onelli, Elisabetta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l127pad9o3qc8lb5rmue3b24hh